Ultrasound

Ultrasound, also referred to as sonography or diagnostic ultrasound, uses high-frequency sound waves to visualize soft tissue. Ultrasounds are frequently ordered to measure fetal anatomy during pregnancy, check for blood clots and to guide needle biopsy procedures of the breast, abdomen and pelvis. The imaging modality does not use any radiation to create images. Find news specific to cardiac ultrasound (echocardiography).

Thumbnail

Genetic variant linked to chemotherapy-induced cardiomyopathy

The same genetic variants that have been uncovered in patients with two other types of cardiomyopathy are also present in an uncommonly high proportion of people with cancer therapy-induced cardiomyopathy (CCM), researchers reported in Circulation.

Ebit (Esaote Group) and DiA Imaging Analysis have partnered offering Advanced AI-based Cardiac Ultrasound Analysis

BE'ER SHEVA, Israel — Genoa, Italy — DiA Imaging Analysis, a leading provider of artificial intelligence (AI)-powered ultrasound analysis tools, announced today that it has partnered with the Italian healthcare IT company Ebit (Esaote Group), to offer DiA’s LVivo Cardiac Toolbox as an integrated part of Ebit's SUITESTENSA CVIS (Cardiovascular Information System) PACS.

Ultrasound societies want the FDA to remove contrast label warning

The International Contrast Ultrasound Society (ICUS) is again urging the FDA to remove the “black box” warning from ultrasound contrast agent (UCA) labels, following its filing of a September 2018 citizen petition with the federal agency.

Thumbnail

American Society of Echocardiography unveils new guidelines for comprehensive TTE

The American Society of Echocardiography has released new guidelines for performing a comprehensive transthoracic echocardiography (TTE) examination. The recommendations, which were endorsed by 22 other cardiology/echocardiography societies from around the world, were published in the January edition of the Journal of the American Society of Echocardiography.

Thumbnail

Prior cardiotoxicity linked to 30% increased risk of CHF during pregnancy

Women with a history of cardiotoxicity from previous cancer treatments are around 30 percent more likely to experience clinical congestive heart failure (CHF) before, during or after pregnancy, according to research published ahead of print in the Journal of the American College of Cardiology.

Thumbnail

FDA-approved AI echocardiogram software bests cardiologists in reducing LVEF variability

A deep-learning software that can automatically calculate left ventricular ejection fraction (LVEF) with less variability than a cardiologist recently received approval from the U.S. Food and Drug Administration (FDA).

Thumbnail

New registry aims to improve quality of cardiovascular imaging

The American Society of Echocardiography (ASE) announced Jan. 29 its ImageGuideEcho registry is open to U.S. physicians. ImageGuideEcho is the first registry exclusively devoted to measuring quality in cardiovascular ultrasounds.

Thumbnail

Genetic variants could be key to identifying chemo-induced cardiotoxicity

As life expectancy continues to expand for cancer patients, clinicians are increasingly dealing with oncological complications like cardiotoxicity, according to a medical team in the Netherlands—and those doctors are met with a paucity of research on the topic.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.